Showing 1,459 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

GSK adds Bristol-Myers pipeline drugs to challenge Gilead in HIV

Editor's pick
FiercePharma
21 December 2015
Hepatitis C treatment

Concern over hepatitis C drug costs only the beginning, health officials say

Editor's pick
The News Tribune
21 December 2015
Access to healthcare

South Africa: New agreement could help end ARV stock outs

Editor's pick
Health-e
21 December 2015
Pharmaceutical industry

Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare

Editor's pick
Bristol-Myers Squibb press release
18 December 2015
Pharmaceutical industry

Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges

Editor's pick
Bloomberg
17 December 2015
Pharmaceutical industry

A New Look Behind the Pricing of a $1,000 Pill

Editor's pick
Open Society Foundations
8 December 2015
Pharmaceutical industry

Gilead Used `Revenue-Driven Pricing' on Hep C Drug, Senators Say

Editor's pick
Bloomberg
1 December 2015
Access to healthcare

Express Scripts backs Imprimis' $1 pill over $750 Daraprim

Editor's pick
Reuters
1 December 2015
Pharmaceutical industry

Martin Shkreli walks back on pledge to lower price of HIV drug Daraprim

Editor's pick
The Guardian
26 November 2015
Hepatitis C treatment

Pricing Pressures: How the Business of Medicine Affects the Price of Therapy

Editor's pick
Healio HCV Next
16 November 2015
Hepatitis C treatment

U.S. FDA approves new indications for Harvoni®, Gilead’s once-daily single tablet regimen for chronic hepatitis C

Editor's pick
Gilled press release
13 November 2015
Pharmaceutical industry

High Cost of HIV Meds, Other Drugs Should Be Top Presidential Concern, Most Americans Say

Editor's pick
The Body
11 November 2015
PrEP

'Significant Victory' as Gilead Expands Co-Pay Assistance for Truvada as PrEP

Editor's pick
Poz
6 November 2015
New & experimental HIV treatments

FDA approves new treatment for HIV

Editor's pick
FDA press release
6 November 2015
Pharmaceutical industry

Why are HIV meds so expensive, and what can we do about it?

Editor's pick
BETA blog
29 October 2015
Pharmaceutical industry

GlaxoSmithKline beats sales forecasts thanks to HIV drugs boost

Editor's pick
The Guardian
28 October 2015
Pharmaceutical industry

Gilead hepatitis C drug sales trend flattens, shares dip

Editor's pick
Reuters
28 October 2015
Access to healthcare

South Africa should override patent on key HIV medicine after widespread stock out problem

Editor's pick
MSF
27 October 2015
Pharmaceutical industry

WikiLeaks publication of complete, final TPP Intellectual Property text confirms pact would raise costs, put medicines out of reach

Editor's pick
Public Citizen
12 October 2015
PrEP

PrEP: The Pathway to Global Access

Editor's pick
TAG
7 October 2015
Access to healthcare

Trade deal is big win for big pharma, health rights advocates say

Editor's pick
Al Jazeera
6 October 2015
Pharmaceutical industry

AIDS Activists Protest Price Gauging of Meds by Hedge Funds

Editor's pick
Poz magazine news
3 October 2015
Pharmaceutical industry

European CHMP adopts positive opinion for Gilead’s single tablet regimen Genvoya® (elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide) for the treatment of HIV

Editor's pick
EATG
1 October 2015
Pharmaceutical industry

Martin Shkreli Is Just a Tiny Part of a Huge Problem

Editor's pick
The Atlantic
28 September 2015